Tags

Type your tag names separated by a space and hit enter

How do you treat patients with myalgia who take statins?
Curr Atheroscler Rep. 2009 Jan; 11(1):9-14.CA

Abstract

3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are safe and effective in lowering low-density lipoprotein cholesterol. As a result, they confer an all-cause mortality benefit across a wide range of patient groups. The utility of statins is limited by their adverse effects, including myalgias and rhabdomyolysis. These clinical events, plus other symptoms, constitute what is termed statin myopathy. This review summarizes current concepts of statin myopathy and presents strategies to minimize statin-associated myopathic complaints.

Authors+Show Affiliations

Division of Cardiology, Hartford Hospital, Hartford, CT 06102, USA.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19080722

Citation

Siddiqi, Saadi A., and Paul D. Thompson. "How Do You Treat Patients With Myalgia Who Take Statins?" Current Atherosclerosis Reports, vol. 11, no. 1, 2009, pp. 9-14.
Siddiqi SA, Thompson PD. How do you treat patients with myalgia who take statins? Curr Atheroscler Rep. 2009;11(1):9-14.
Siddiqi, S. A., & Thompson, P. D. (2009). How do you treat patients with myalgia who take statins? Current Atherosclerosis Reports, 11(1), 9-14.
Siddiqi SA, Thompson PD. How Do You Treat Patients With Myalgia Who Take Statins. Curr Atheroscler Rep. 2009;11(1):9-14. PubMed PMID: 19080722.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - How do you treat patients with myalgia who take statins? AU - Siddiqi,Saadi A, AU - Thompson,Paul D, PY - 2008/12/17/entrez PY - 2008/12/17/pubmed PY - 2009/4/1/medline SP - 9 EP - 14 JF - Current atherosclerosis reports JO - Curr Atheroscler Rep VL - 11 IS - 1 N2 - 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are safe and effective in lowering low-density lipoprotein cholesterol. As a result, they confer an all-cause mortality benefit across a wide range of patient groups. The utility of statins is limited by their adverse effects, including myalgias and rhabdomyolysis. These clinical events, plus other symptoms, constitute what is termed statin myopathy. This review summarizes current concepts of statin myopathy and presents strategies to minimize statin-associated myopathic complaints. SN - 1534-6242 UR - https://www.unboundmedicine.com/medline/citation/19080722/How_do_you_treat_patients_with_myalgia_who_take_statins L2 - https://medlineplus.gov/cholesterolmedicines.html DB - PRIME DP - Unbound Medicine ER -